Ropes & Gray Advises $110M Registered Direct Offering for Foghorn Therapeutics
May 24, 2024
May 24, 2024
BOSTON, Massachusetts, May 24 -- Ropes and Gray, a law firm, issued the following news on May 23, 2024:
Ropes & Gray represented Foghorn Therapeutics in its registered direct offering of 12,743,039 shares of common stock $5.51 per share, and, to certain investors in lieu of common stock, pre-funded warrants to purchase up to an aggregate of 7,220,794 shares of its common stock for total gross proceeds of approximately $110 million. The closing was announced in a May 22 press rel . . .
Ropes & Gray represented Foghorn Therapeutics in its registered direct offering of 12,743,039 shares of common stock $5.51 per share, and, to certain investors in lieu of common stock, pre-funded warrants to purchase up to an aggregate of 7,220,794 shares of its common stock for total gross proceeds of approximately $110 million. The closing was announced in a May 22 press rel . . .